medical regulators

US health insurers warn that AI-driven medical billing and coding could add billions of dollars in unnecessary claims and raise overall healthcare costs. Medical billing and coding companies reject the claim, arguing that AI improves accuracy and efficiency rather than driving up spending. The dispute comes as regulators and providers weigh how quickly artificial intelligence should be adopted across the healthcare revenue cycle.

Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.

Vermont regulators are receiving greater transparency into the state's medical education programs after pushing for more openness. The development follows demands from oversight bodies seeking clearer information about how medical training is run and monitored in the state. Exact details of what is being disclosed, and by which institutions, remain limited in early reporting.

Oregon state officials are warning residents about low-cost health insurance plans that provide far less coverage than consumers may expect. Regulators caution that these plans can leave people exposed to large medical bills when they actually need care. The alert comes during the period when residents are weighing their health coverage options, and officials are urging buyers to review what a plan actually covers before enrolling.